Mike Evers, Author at ORTHOWORLD

Stryker Drives Q1 Growth in Face of Huge Comparisons

The company's orthopedic sales grew in the high-single-digits for 1Q24 against massive 2023 comparisons fueled by backlogged procedures.

May 02, 2024

The company's nView S1 imaging and navigation system completed its first adult spine surgery after more than 250 successful pediatric cases.

Apr 29, 2024

The company completed a $11.5 million funding round to progress a clinical study of LDGraft, a bone graft substitute for spinal fusion.

Apr 29, 2024

The company's orthopedic sales grew in the low single digits for 1Q24, but CONMED faced outsized comparisons and lingering supply issues.

Apr 25, 2024

The company grew in the mid-single-digits for 1Q24 but was aided by an unusually robust joint replacement market and one-time revenue items.

Apr 18, 2024

According to our estimates, just under 50 companies accounted for more than 85% of all orthopedic revenue in 2023.

Apr 10, 2024

Zimmer Biomet's Nnamdi Njoku talks about the company's goal of supporting surgeons undertaking complex surgeries with ROSA Shoulder.

Apr 02, 2024

While Orthofix's trauma business is growing slower than the market, it has an enormous opportunity in the U.S.

Mar 18, 2024

Stay up to date on the orthopedic market's 4Q performance in 2023 as we update this post with company sales data and industry developments.

Mar 18, 2024

The company grew in the low double-digits in 2023 but a strategic review revealed Anika's need to focus on the greatest growth opportunities.

Mar 15, 2024